Meclofenoxate
Meclofenoxate, also known as centrophenoxine, is a relatively new nootropic drug for the treatment of a variety of dementia including Alzheimer's disease.
Meclofenoxate Facts
| Other names | Meclofenoxate, Centrophenoxine, Lucidril, Acephen |
| Chemical formula | C12H16ClNO3 |
| Effects | Used to treat the symptoms of dementia. |
| Dosage | 250-500mg 1 to 3 times a day (in nootropic use) |
| Prize | 60x250mg $30 |
Meclofenoxate is made up of DMAE and parachlorophenoxyacetate (pCPA). DMAE is found in canned foods like sardines and pCPA is a synthetic compound. Research indicates the DMAE acts like a "false neurotransmitter" in the brain and is able to improve brain functions.
Anecdotal reports suggest that the drug can improve cognition, memory, attention span and alertness in some patients with dementias. Not all patients with dementia respond to the drug. Whether it can prevent dementias is not known but a few studies indicate that it can slow the progression of Alzheimer's disease.
Besides causing hyper alertness, the drug can cause dizziness and nausea. Since all nootropics work similarly, it is recommended that one not combine two similar drugs. One needs to take the drug on a daily basis for at least a few months to see the benefits. If excessive alertness and hyperactivity occurs, it is recommended that the drug be held for a few days.